Market Tracker

07/23 6:56am ET

Immunomedics Inc (NASDAQ:IMMU)

3.43
Data as of Jul 22
 +0.06 / +1.78%
Today’s Change
3.04
Today|||52-Week Range
7.35
-25.43%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close3.37
Today’s open3.41
Day’s range-- - --
Volume332,584
Average volume (3 months)771,571
Market cap$281.4M
Dividend yield--
Data as of 07/22/2014

Growth & Valuation

Earnings growth (last year)-1,700.00%
Earnings growth (this year)-146.87%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-84.84%
P/E ratioNM
Price/Sales85.56
Price/Book7.55

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc+1.05+6.91%
CLDNCelladon Corp+0.38+2.70%
LMNSLumenis Ltd+0.36+3.96%
TEARTearLab Corp+0.08+1.52%
Data as of 07/22/2014

Financials

Next reporting dateAugust 28, 2014
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$5.0M
Annual profit (last year)-$12.2M
Net profit margin-245.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts